{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:03:30Z","timestamp":1784088210782,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Basque Country Government","award":["MTVD20\/BCB\/024"],"award-info":[{"award-number":["MTVD20\/BCB\/024"]}]},{"name":"Basque Government\u2019s Department of Health - Research Intensification Program","award":["2024222008"],"award-info":[{"award-number":["2024222008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Ophthalmic viscosurgical devices (OVDs) are essential in cataract surgery for maintaining anterior chamber stability and protecting intraocular tissues. This study evaluated the physicochemical and rheological properties of three hyaluronic acid\u2013based OVDs (OpHLINE\n                      <jats:sup>\u00ae<\/jats:sup>\n                      1.4%, 2%, and 3%) and assessed their clinical performance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A two-phase investigation was conducted: (1) characterization of OpHLINE formulations versus four commercial comparators, including cohesive\u2013dispersive analysis and viscosity\u2013shear profiling; and (2) a prospective clinical trial in 68 patients undergoing phacoemulsification with intraocular lens implantation. Primary endpoint was workspace maintenance; secondary endpoints included ease of OVD removal, endothelial cell density (ECD) loss, and intraocular pressure (IOP) changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>By varying HA concentration at constant molecular weight, we achieved direct control of rheological properties and CDI, generating distinct functional profiles: OpHLINE 1.4% behaved cohesively with rapid aspiration, OpHLINE 3% exhibited dispersive-like retention while maintaining space, and OpHLINE 2% combined cohesive handling with the highest shear-resistant viscosity. Clinically, OpHLINE 2% maintained an intermediate behaviour regarding space maintenance, ease of removal, ECD and IOP, while OpHLINE 3% provided the highest full chamber maintenance during all surgical steps. OpHLINE 1.4% enabled the easiest removal (95% adequate) and the lowest ECD loss (12.9%). IOP spikes\u2009\u2265\u200930 mmHg occurred in 13.6%, 20.8%, and 30.4% of eyes at 6\u00a0h for 1.4%, 2%, and 3%, respectively, resolving without sequelae.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study demonstrates that cohesive\u2013dispersive behaviour and shear-dependent viscosity can be predictably tuned by HA concentration alone, enabling a modular, evidence-based approach to OVD selection. OpHLINE series provide evidence for three distinct behaviours: 1.4% showed optimal removal and endothelial protection; 2% offered balanced rheological and clinical properties; 3% provided the most consistent anterior chamber stability during surgery. These results allow surgeons to tailor intraoperative performance without altering polymer chain length.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>This study was retrospectively registered (OpHLINE-PIC01-2020), approved on 8 February 2021 by the Ethics Committee for Research with Medicines of Euskadi (CEIm-E, Spain, code PS2020065). Trial Registration: ClinicalTrials.gov, NCT ID Number NCT07343973, Registered on 07 January 2026.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-026-04924-4","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:59:38Z","timestamp":1779278378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hyaluronic acid concentration predictably modulates physicochemical properties and clinical performance in ophthalmic viscosurgical devices: integrated laboratory and prospective clinical assessment"],"prefix":"10.1186","volume":"26","author":[{"given":"Alejandro","family":"Melero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josune","family":"Torrecilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ander","family":"Pino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Coello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"S\u00e1ez de Arregui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzaga","family":"Garay-Aramburu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"L\u00f3pez-Plandolit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaia","family":"Guergu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iker","family":"Henares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaia","family":"Huguet-Casquero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Ucelay L\u00f3pez de Heredia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"P\u00e9rez Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"4924_CR1","doi-asserted-by":"publisher","unstructured":"Lam D, Rao SK, Ratra V, Liu Y, Mitchell P, King J, et al. Cataract. Nat Rev Dis Primers. 2015;1: Article number: 15014. https:\/\/doi.org\/10.1038\/nrdp.2015.14","DOI":"10.1038\/nrdp.2015.14"},{"key":"4924_CR2","doi-asserted-by":"publisher","unstructured":"Lin L, Liang Y, Jiang G, Gan Q, Yang T, Liao P, et al. Global, regional, and national burden of cataract: a comprehensive analysis and projections from 1990 to 2021. PLoS One. 2025;20 6 June. https:\/\/doi.org\/10.1371\/journal.pone.0326263.","DOI":"10.1371\/journal.pone.0326263"},{"key":"4924_CR3","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.jcrs.2014.04.025","volume":"40","author":"FTA Kretz","year":"2014","unstructured":"Kretz FTA, Limberger IJ, Auffarth GU. Corneal endothelial cell coating during phacoemulsification using a new dispersive hyaluronic acid ophthalmic viscosurgical device. J Cataract Refract Surg. 2014;40:1879\u201384. https:\/\/doi.org\/10.1016\/j.jcrs.2014.04.025.","journal-title":"J Cataract Refract Surg"},{"key":"4924_CR4","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s40123-021-00403-9","volume":"10","author":"AF Borkenstein","year":"2021","unstructured":"Borkenstein AF, Borkenstein EM, Malyugin B. Ophthalmic Viscosurgical Devices (OVDs) in Challenging Cases: a Review. Ophthalmol Therapy. 2021;10:831\u201343. https:\/\/doi.org\/10.1007\/s40123-021-00403-9.","journal-title":"Ophthalmol Therapy"},{"key":"4924_CR5","doi-asserted-by":"publisher","unstructured":"Arshinoff SA, The use of ophthalmic, viscosurgical devices in cataract surgery. Hyaluronan. Elsevier; 2002(2):119\u201328. https:\/\/doi.org\/10.1533\/9781845693121.119","DOI":"10.1533\/9781845693121.119"},{"key":"4924_CR6","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1016\/j.jcrs.2005.08.056","volume":"31","author":"SA Arshinoff","year":"2005","unstructured":"Arshinoff SA, Jafari M. New classification of ophthalmic viscosurgical devices \u2013 2005. J Cataract Refract Surg. 2005;31:2167\u201371. https:\/\/doi.org\/10.1016\/j.jcrs.2005.08.056.","journal-title":"J Cataract Refract Surg"},{"key":"4924_CR7","doi-asserted-by":"crossref","unstructured":"Arshinoff SA. Dispersive-cohesive viscoelastic soft shell technique. J Cataract Refract Surg. 1999;25(2):167\u201373.","DOI":"10.1016\/S0886-3350(99)80121-7"},{"key":"4924_CR8","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.jcrs.2013.06.011","volume":"39","author":"SA Arshinoff","year":"2013","unstructured":"Arshinoff SA, Norman R. Tri-soft shell technique. J Cataract Refract Surg. 2013;39:1196\u2013203. https:\/\/doi.org\/10.1016\/j.jcrs.2013.06.011.","journal-title":"J Cataract Refract Surg"},{"key":"4924_CR9","doi-asserted-by":"publisher","unstructured":"WatanabeI, Hoshi H, Sato M, Suzuki K. Rheological and adhesive properties to identify cohesive and dispersive ophthalmic viscosurgical devices. Chem Pharm Bull (Tokyo). 2019;67(3):277\u2013283. https:\/\/doi.org\/10.1248\/cpb.c18-00890","DOI":"10.1248\/cpb.c18-00890"},{"key":"4924_CR10","doi-asserted-by":"publisher","unstructured":"Yildirim TM, Auffarth GU, Son HS, Khoramnia R, Munro DJ, Merz PR. Dispersive viscosurgical devices demonstrate greater efficacy in protecting corneal endothelium in vitro. BMJ Open Ophthalmol. 2019;4. https:\/\/doi.org\/10.1136\/bmjophth-2018-000227.","DOI":"10.1136\/bmjophth-2018-000227"},{"key":"4924_CR11","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/S0886-3350(98)80109-0","volume":"24","author":"JF Poyer","year":"1998","unstructured":"Poyer JF, Chan KY, Arshinoff SA. Quantitative method to determine the cohesion of viscoelastic agents by dynamic aspiration. J Cataract Refract Surg. 1998;24:1130\u20135. https:\/\/doi.org\/10.1016\/S0886-3350(98)80109-0.","journal-title":"J Cataract Refract Surg"},{"key":"4924_CR12","unstructured":"Pocock SJ, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (StroBE) statement: guidelines for reporting observational studies."},{"key":"4924_CR13","volume-title":"Biolon\u00ae Ophthalmic Viscosurgical Device: Instructions for Use","author":"Altacor Ltd","year":"2024","unstructured":"Altacor Ltd. Biolon\u00ae Ophthalmic Viscosurgical Device: Instructions for Use. Cambridge, UK: Altacor Ltd; 2024."},{"key":"4924_CR14","volume-title":"General (Israel) Ltd. Biolon Prime\u00ae Ophthalmic Viscosurgical Device: Instructions for Use","author":"Bio-Technology","year":"2024","unstructured":"Bio-Technology. General (Israel) Ltd. Biolon Prime\u00ae Ophthalmic Viscosurgical Device: Instructions for Use. Be\u2019er Tuvia, Israel: BTG; 2024."},{"key":"4924_CR15","volume-title":"Microvisc\u00ae Ophthalmic Viscosurgical Device: Instructions for Use","author":"AB Bohus BioTech","year":"2024","unstructured":"Bohus BioTech AB. Microvisc\u00ae Ophthalmic Viscosurgical Device: Instructions for Use. Str\u00f6mstad, Sweden: Bohus BioTech; 2024."},{"key":"4924_CR16","volume-title":"BBTVisc\u00ae Ophthalmic Viscosurgical Device: Instructions for Use","author":"AB Bohus BioTech","year":"2024","unstructured":"Bohus BioTech AB. BBTVisc\u00ae Ophthalmic Viscosurgical Device: Instructions for Use. Str\u00f6mstad, Sweden: Bohus BioTech; 2024."},{"key":"4924_CR17","unstructured":"American academy of ophthalmology. ophthalmic viscosurgical devices. 2025. https:\/\/eyewiki.org\/Ophthalmic_Viscosurgical_Devices. Accessed 19 Sep 2025."},{"key":"4924_CR18","doi-asserted-by":"publisher","unstructured":"Benjamin L. Fluidics and rheology in phaco surgery: What matters and what is the hype? Eye (Basingstoke). 2018;32:204\u20139. https:\/\/doi.org\/10.1038\/eye.2017.299","DOI":"10.1038\/eye.2017.299"},{"key":"4924_CR19","doi-asserted-by":"crossref","unstructured":"Liesegang TJ. Viscoelastic substances in ophthalmology. Surv Ophthalmol. 1990;34(4):268\u201393.","DOI":"10.1016\/0039-6257(90)90027-S"},{"key":"4924_CR20","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.2147\/OPTH.S520105","volume":"19","author":"I Watanabe","year":"2025","unstructured":"Watanabe I, Mukuno H. Modelling of the Soft Shell Technique Using Computational Fluid Dynamics. Clin Ophthalmol. 2025;19:1427\u201333. https:\/\/doi.org\/10.2147\/OPTH.S520105.","journal-title":"Clin Ophthalmol"},{"key":"4924_CR21","doi-asserted-by":"publisher","unstructured":"Burkhard H, Schwenn D. O. Viscoelastics in ophthalmic surgery. 1st edition. Heidelberg: Springer Berlin; 2000. https:\/\/doi.org\/10.1007\/978-3-642-59779-4.","DOI":"10.1007\/978-3-642-59779-4"},{"key":"4924_CR22","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1136\/bjo.2005.085969","volume":"90","author":"T Oshika","year":"2006","unstructured":"Oshika T, Okamoto F, Kaji Y, Hiraoka T, Kiuchi T, Sato M, et al. Retention and removal of a new viscous dispersive ophthalmic viscosurgical device during cataract surgery in animal eyes. Br J Ophthalmol. 2006;90:485\u20137. https:\/\/doi.org\/10.1136\/bjo.2005.085969.","journal-title":"Br J Ophthalmol"},{"key":"4924_CR23","doi-asserted-by":"crossref","unstructured":"Dick HB, Krummenauer F, Augustin AJ, Pakula T, Pfeiffer N. Healon5 viscoadaptive formulation: Comparison to Healon and Healon GV. J Cataract Refract Surg. 2001;27(2):320\u20136.","DOI":"10.1016\/S0886-3350(00)00482-X"},{"key":"4924_CR24","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/j.jcrs.0000000000000507","volume":"47","author":"S Arshinoff","year":"2021","unstructured":"Arshinoff S, Hofmann I, Nae H. Rheological behavior of commercial artificial tear solutions. J Cataract Refract Surg. 2021;47:649\u201354. https:\/\/doi.org\/10.1097\/j.jcrs.0000000000000507.","journal-title":"J Cataract Refract Surg"},{"key":"4924_CR25","unstructured":"Cuan Aguilar Y, Da RO, Ramos S, Montero D\u00edaz E, Puertas IFH, Candelaria EDCP, et al. Factores asociados a la hipertensi\u00f3n ocular despu\u00e9s de una facoemulsificaci\u00f3n no complicada Patient factors associated to ocular hypertension after uncomplicated phacoemulsification. Rev Cubana de Oftalmolog\u00eda. 2018;31(2):1\u201311."},{"key":"4924_CR26","doi-asserted-by":"publisher","DOI":"10.14744\/bej.2019.09609","author":"B Acar","year":"2019","unstructured":"Acar B. The Outcomes of a Dispersive Ophthalmic Viscosurgical Device. Beyoglu Eye J. 2019; 5(1):12\u201316. https:\/\/doi.org\/10.14744\/bej.2019.09609","journal-title":"Beyoglu Eye J"},{"key":"4924_CR27","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.2147\/opth.s22243","volume":"5","author":"SS Modi","year":"2011","unstructured":"Modi SS, Davison JA, Walters T. Safety, efficacy, and intraoperative characteristics of DisCoVisc and Healon ophthalmic viscosurgical devices for cataract surgery. Clin Ophthalmol. 2011;5:1381\u20139. https:\/\/doi.org\/10.2147\/opth.s22243.","journal-title":"Clin Ophthalmol"},{"key":"4924_CR28","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S0886-3350(02)01649-8","volume":"29","author":"PG Tranos","year":"2003","unstructured":"Tranos PG, Wickremasinghe SS, Hildebrand D, Asaria R, Mearza A, Ghazi-Nouri S, et al. Same-day versus first-day review of intraocular pressure after uneventful phacoemulsification. J Cataract Refract Surg. 2003;29:508\u201312. https:\/\/doi.org\/10.1016\/S0886-3350(02)01649-8.","journal-title":"J Cataract Refract Surg"},{"key":"4924_CR29","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/sj.eye.6701319","volume":"18","author":"P Tranos","year":"2004","unstructured":"Tranos P, Bhar G, Little B. Postoperative intraocular pressure spikes: The need to treat. Eye. 2004;18:673\u20139. https:\/\/doi.org\/10.1038\/sj.eye.6701319.","journal-title":"Eye"},{"key":"4924_CR30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0146-2776(83)80062-7","volume":"9","author":"A Tuberville","year":"1983","unstructured":"Tuberville A, Tomoda T, Nissenkorn I, Wood TO. Postsurgical intraocular pressure elevation. Am Intra-Ocular Implant Soc J. 1983;9:309\u201312. https:\/\/doi.org\/10.1016\/S0146-2776(83)80062-7.","journal-title":"Am Intra-Ocular Implant Soc J"},{"key":"4924_CR31","doi-asserted-by":"crossref","unstructured":"Ike Ahmed IK, Kranemann C, Chipman M, Malam F. Revisiting early postoperative follow-up after phacoemulsification. J Cataract Refract Surg. 2002;28(1):100\u20138.","DOI":"10.1016\/S0886-3350(01)00994-4"},{"key":"4924_CR32","unstructured":"Corsino Fern\u00e1ndez-Vila P, Sevillano C. Control de picos tensionales postquir\u00fargicos. In: SECOIR. 136th edition. 2012."},{"key":"4924_CR33","doi-asserted-by":"crossref","unstructured":"J\u00fcrgens I, Matheu A, Castilla M. Ocular hypertension after cataract surgery: a comparison of three surgical techniques and two viscoelastics. Ophthalmic Surg Lasers. 1997;28(1):30\u20136.","DOI":"10.3928\/1542-8877-19970101-07"},{"key":"4924_CR34","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/0002-9394(83)90388-4","volume":"95","author":"FG Berson","year":"1983","unstructured":"Berson FG, Patterson MM, Epstein DL. Obstruction of aqueous outflow by sodium hyaluronate in enucleated human eyes. Am J Ophthalmol. 1983;95:668\u201372. https:\/\/doi.org\/10.1016\/0002-9394(83)90388-4.","journal-title":"Am J Ophthalmol"},{"key":"4924_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1600-0420.2006.00784.x","volume":"85","author":"A Storr-Paulsen","year":"2007","unstructured":"Storr-Paulsen A, N\u00f8rregaard JC, Farik G, T\u00e5rnh\u00f8j J. The influence of viscoelastic substances on the corneal endothelial cell population during cataract surgery: A prospective study of cohesive and dispersive viscoelastics. Acta Ophthalmol Scand. 2007;85:183\u20137. https:\/\/doi.org\/10.1111\/j.1600-0420.2006.00784.x.","journal-title":"Acta Ophthalmol Scand"},{"key":"4924_CR36","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jcjo.2018.08.005","volume":"54","author":"JY Choi","year":"2019","unstructured":"Choi JY, Han YK. Long-term (\u2265 10 years) results of corneal endothelial cell loss after cataract surgery. Can J Ophthalmol. 2019;54:438\u201344. https:\/\/doi.org\/10.1016\/j.jcjo.2018.08.005.","journal-title":"Can J Ophthalmol"},{"key":"4924_CR37","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.2147\/OPTH.S411454","volume":"17","author":"MC Vital","year":"2023","unstructured":"Vital MC, Jong KY, Trinh CE, Starck T, Sretavan D. Endothelial Cell Loss Following Cataract Surgery Using Continuous Curvilinear Capsulorhexis or Precision Pulse Capsulotomy. Clin Ophthalmol. 2023;17:1701\u20138. https:\/\/doi.org\/10.2147\/OPTH.S411454.","journal-title":"Clin Ophthalmol"},{"key":"4924_CR38","doi-asserted-by":"publisher","unstructured":"Wood K, Pessach Y, Kovalyuk N, Lifshitz M, Winter H, Pikkel J. Corneal endothelial cell loss and intraocular pressure following phacoemulsification using a new viscous-cohesive ophthalmic viscosurgical device. Int Ophthalmol. 2024;44. https:\/\/doi.org\/10.1007\/s10792-024-02997-y.","DOI":"10.1007\/s10792-024-02997-y"},{"key":"4924_CR39","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1097\/j.jcrs.0000000000001473","volume":"50","author":"L De Rosa","year":"2024","unstructured":"De Rosa L, Furiosi L, Pellegrini M, Yu AC, Scorcia V, Busin M. Prospective randomized clinical trial evaluating efficacy and safety of a new ophthalmic viscosurgical device in patients undergoing cataract surgery. J Cataract Refract Surg. 2024;50:906\u201311. https:\/\/doi.org\/10.1097\/j.jcrs.0000000000001473.","journal-title":"J Cataract Refract Surg"},{"key":"4924_CR40","doi-asserted-by":"publisher","unstructured":"Bourne WM, Brubaker RF. Michael O\u2019fallon; W. Use of air to decrease endothelial cell loss during intraocular lens implantation. Arch Ophthalmol. 1979;97(8):1473\u20135. https:\/\/doi.org\/10.1001\/archopht.1979.01020020135009","DOI":"10.1001\/archopht.1979.01020020135009"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-04924-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04924-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04924-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:03:31Z","timestamp":1784084611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-04924-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4924"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-04924-4","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved on 8 February 2021 by the Ethics Committee for Research with Medicines of Euskadi (CEIm-E), code PS2020065, which belongs to the Department of Health of the Basque Government (Spain). The protocol (OpHLINE-PIC01-2020), subject information sheet, and informed consent form were reviewed and approved in accordance with the revised World Medical Association Declaration of Helsinki (2013), UNE-EN ISO 14155:2021, and CPMP\/ICH-GCP-E6\/135\/95 guidelines. All participants provided written informed consent prior to enrolment. Trial registration: ClinicalTrials.gov, NCT ID Number NCT07343973, registered on 07 January 2026.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This manuscript does not contain any individual person\u2019s data in any form.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RP is the Scientific Director and AHC is the Chief Operations Officer of i+Med S.Coop., the company that commercializes OpHLINE\n                      \u00ae\n                      . AP, JT, AM, JMA and MULH are employees at i+Med S.Coop. The remaining authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"414"}}